» Articles » PMID: 21363962

The Anti-tumor Drug E7107 Reveals an Essential Role for SF3b in Remodeling U2 SnRNP to Expose the Branch Point-binding Region

Overview
Journal Genes Dev
Specialty Molecular Biology
Date 2011 Mar 3
PMID 21363962
Citations 108
Authors
Affiliations
Soon will be listed here.
Abstract

Duplex formation between the branch point-binding region (BBR) of U2 snRNA and the branch point sequence (BPS) in the intron is essential for splicing. Both the BBR and BPS interact with the U2 small nuclear ribonucleoprotein (snRNP)-associated SF3b complex, which is the target of the anti-tumor drug E7107. We show that E7107 blocks spliceosome assembly by preventing tight binding of U2 snRNP to pre-mRNA. E7107 has no apparent effect on U2 snRNP integrity. Instead, E7107 abolishes an ATP-dependent conformational change in U2 snRNP that exposes the BBR. We conclude that SF3b is required for this remodeling, which exposes the BBR for tight U2 snRNP binding to pre-mRNA.

Citing Articles

RNA-binding proteins as therapeutic targets in cancer.

Jungfleisch J, Gebauer F RNA Biol. 2025; 22(1):1-8.

PMID: 40016176 PMC: 11869776. DOI: 10.1080/15476286.2025.2470511.


Targeting RNA splicing modulation: new perspectives for anticancer strategy?.

Lv X, Sun X, Gao Y, Song X, Hu X, Gong L J Exp Clin Cancer Res. 2025; 44(1):32.

PMID: 39885614 PMC: 11781073. DOI: 10.1186/s13046-025-03279-w.


SF3B1: from core splicing factor to oncogenic driver.

Bak-Gordon P, Manley J RNA. 2025; 31(3):314-332.

PMID: 39773890 PMC: 11874996. DOI: 10.1261/rna.080368.124.


SF3B1 thermostability as an assay for splicing inhibitor interactions.

Amorello A, Chandrashekar Reddy G, Melillo B, Cravatt B, Ghosh A, Jurica M J Biol Chem. 2024; 301(2):108135.

PMID: 39725033 PMC: 11791315. DOI: 10.1016/j.jbc.2024.108135.


The Impact of Spliceosome Inhibition in SF3B1-Mutated Uveal Melanoma.

Nguyen J, Drabarek W, Leeflang A, Brands T, van den Bosch T, Verdijk R Invest Ophthalmol Vis Sci. 2024; 65(12):11.

PMID: 39374010 PMC: 11463709. DOI: 10.1167/iovs.65.12.11.


References
1.
Newnham C, Query C . The ATP requirement for U2 snRNP addition is linked to the pre-mRNA region 5' to the branch site. RNA. 2001; 7(9):1298-309. PMC: 1370173. DOI: 10.1017/s1355838201010561. View

2.
Das R, Dufu K, Romney B, Feldt M, Elenko M, Reed R . Functional coupling of RNAP II transcription to spliceosome assembly. Genes Dev. 2006; 20(9):1100-9. PMC: 1472470. DOI: 10.1101/gad.1397406. View

3.
Stoilov P, Lin C, Damoiseaux R, Nikolic J, Black D . A high-throughput screening strategy identifies cardiotonic steroids as alternative splicing modulators. Proc Natl Acad Sci U S A. 2008; 105(32):11218-23. PMC: 2516208. DOI: 10.1073/pnas.0801661105. View

4.
Smith D, Query C, Konarska M . "Nought may endure but mutability": spliceosome dynamics and the regulation of splicing. Mol Cell. 2008; 30(6):657-66. PMC: 2610350. DOI: 10.1016/j.molcel.2008.04.013. View

5.
REED R . Initial splice-site recognition and pairing during pre-mRNA splicing. Curr Opin Genet Dev. 1996; 6(2):215-20. DOI: 10.1016/s0959-437x(96)80053-0. View